ZA201805080B - Application of triacetyl-3-hydroxyphenyladenosine in preparation of pharmaceutical drug for preventing or treating non-alcoholic fatty liver disease - Google Patents
Application of triacetyl-3-hydroxyphenyladenosine in preparation of pharmaceutical drug for preventing or treating non-alcoholic fatty liver diseaseInfo
- Publication number
- ZA201805080B ZA201805080B ZA201805080A ZA201805080A ZA201805080B ZA 201805080 B ZA201805080 B ZA 201805080B ZA 201805080 A ZA201805080 A ZA 201805080A ZA 201805080 A ZA201805080 A ZA 201805080A ZA 201805080 B ZA201805080 B ZA 201805080B
- Authority
- ZA
- South Africa
- Prior art keywords
- hydroxyphenyladenosine
- triacetyl
- preventing
- preparation
- application
- Prior art date
Links
- VOGJLGJXZOVCHK-DXBBTUNJSA-N 1-[(2R,3S,4R,5R)-3,4-diacetyl-5-(6-aminopurin-9-yl)-3,4-dihydroxy-2-(hydroxymethyl)-5-(3-hydroxyphenyl)oxolan-2-yl]ethanone Chemical compound C(C)(=O)[C@]1([C@]([C@]([C@@](O1)(N1C=NC=2C(N)=NC=NC1=2)C1=CC(=CC=C1)O)(O)C(C)=O)(O)C(C)=O)CO VOGJLGJXZOVCHK-DXBBTUNJSA-N 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 208000008338 non-alcoholic fatty liver disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201511034199 | 2015-12-31 | ||
| PCT/CN2016/112623 WO2017114413A1 (zh) | 2015-12-31 | 2016-12-28 | 三乙酰基-3-羟基苯基腺苷在制备预防或者治疗非酒精性脂肪肝药物中的应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201805080B true ZA201805080B (en) | 2019-10-30 |
Family
ID=59224622
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA201805080A ZA201805080B (en) | 2015-12-31 | 2018-07-27 | Application of triacetyl-3-hydroxyphenyladenosine in preparation of pharmaceutical drug for preventing or treating non-alcoholic fatty liver disease |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11058703B2 (enExample) |
| EP (1) | EP3398604A4 (enExample) |
| JP (1) | JP7382716B2 (enExample) |
| KR (1) | KR102676056B1 (enExample) |
| CN (2) | CN106943420A (enExample) |
| AU (1) | AU2016383376B2 (enExample) |
| CA (1) | CA3010097C (enExample) |
| HK (1) | HK1255689A1 (enExample) |
| RU (1) | RU2759916C2 (enExample) |
| WO (1) | WO2017114413A1 (enExample) |
| ZA (1) | ZA201805080B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107334775A (zh) * | 2016-03-14 | 2017-11-10 | 中国医学科学院药物研究所 | 三乙酰基-3-羟基苯基腺苷在制备治疗动脉粥样硬化药物中的应用 |
| KR20210016407A (ko) * | 2018-06-05 | 2021-02-15 | 플래그쉽 파이어니어링 이노베이션스 브이, 인크. | 대사 장애 및 비알코올성 지방 간 질환의 치료를 위한 활성제 및 그 사용 방법 |
| CN111821313A (zh) * | 2019-04-17 | 2020-10-27 | 江苏天士力帝益药业有限公司 | 三乙酰基-3-羟基苯基腺苷在制备抑制心脏纤维化的药物中的应用 |
| CN114869901B (zh) * | 2022-05-06 | 2023-10-27 | 安徽医科大学 | 马鞭草苷在治疗酒精性肝损伤药物中的应用 |
| CN117599076A (zh) * | 2023-11-15 | 2024-02-27 | 中国医学科学院药物研究所 | 三乙酰基-3-羟基苯基腺苷在制备运动模拟药物中的应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005132812A (ja) | 2003-10-08 | 2005-05-26 | Kobayashi Pharmaceut Co Ltd | シイタケ菌糸体抽出物の分画物およびその用途 |
| CN100427534C (zh) * | 2004-03-19 | 2008-10-22 | 四川大学 | 聚合物型含磷阻燃剂及其制备方法和用途 |
| JP2007210926A (ja) | 2006-02-08 | 2007-08-23 | Tokyo Univ Of Pharmacy & Life Science | ピラジンカルボン酸化合物からなる薬剤、及び食餌 |
| CN101712709A (zh) | 2008-10-06 | 2010-05-26 | 中国医学科学院药物研究所 | 三乙酰基-3-羟基苯基腺苷及其调血脂的用途 |
| JP5688229B2 (ja) | 2010-03-19 | 2015-03-25 | 国立大学法人名古屋大学 | 肝保護作用を有するタンパク質、肝障害予防・保護用化合物のスクリーニング方法 |
| CN102125580A (zh) * | 2011-01-17 | 2011-07-20 | 泰山医学院 | 三乙酰基-3-羟基苯基腺苷thpa在制药中的应用 |
| ME02312B (me) * | 2011-04-22 | 2016-06-20 | Pfizer | DERIVATI PIRAZOLOSPIROKETONA, NAMIJENJENI UPOTREBI KAO INHIBITORI ACETIL-CoA-KARBOKSILAZE |
| AU2013204500A1 (en) | 2012-09-21 | 2014-04-10 | Barbara Jane Badenoch-Jones | Novel AMPK agonist compositions and methods of use |
| CN103191145A (zh) | 2013-03-27 | 2013-07-10 | 南京理工大学 | 腺苷及其衍生物在防治药物性肝损伤中的应用 |
| CN104211747B (zh) * | 2013-05-29 | 2018-09-25 | 中国医学科学院药物研究所 | 5’-磷酸-n6-（3-羟基苯基）腺苷的制备及医药用途 |
| US9827222B2 (en) | 2013-07-01 | 2017-11-28 | Emory University | Treating or preventing nephrogenic diabetes insipidus |
| CN104546887B (zh) * | 2013-10-09 | 2018-10-30 | 中国医学科学院药物研究所 | 虫草素衍生物治疗炎症疾病的用途 |
| CN105663152A (zh) | 2014-11-19 | 2016-06-15 | 中国医学科学院药物研究所 | 三乙酰基-3-羟基苯基腺苷在制备改善胰岛素抵抗及相关疾病中的应用 |
| CN107334775A (zh) * | 2016-03-14 | 2017-11-10 | 中国医学科学院药物研究所 | 三乙酰基-3-羟基苯基腺苷在制备治疗动脉粥样硬化药物中的应用 |
-
2016
- 2016-12-28 KR KR1020187021547A patent/KR102676056B1/ko active Active
- 2016-12-28 AU AU2016383376A patent/AU2016383376B2/en active Active
- 2016-12-28 HK HK18114837.8A patent/HK1255689A1/en unknown
- 2016-12-28 EP EP16881202.2A patent/EP3398604A4/en active Pending
- 2016-12-28 US US16/067,228 patent/US11058703B2/en active Active
- 2016-12-28 WO PCT/CN2016/112623 patent/WO2017114413A1/zh not_active Ceased
- 2016-12-28 CA CA3010097A patent/CA3010097C/en active Active
- 2016-12-28 RU RU2018126158A patent/RU2759916C2/ru active
- 2016-12-28 JP JP2018533743A patent/JP7382716B2/ja active Active
- 2016-12-31 CN CN201611266703.4A patent/CN106943420A/zh active Pending
- 2016-12-31 CN CN202410227642.9A patent/CN118178446A/zh active Pending
-
2018
- 2018-07-27 ZA ZA201805080A patent/ZA201805080B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP7382716B2 (ja) | 2023-11-17 |
| US20190022120A1 (en) | 2019-01-24 |
| AU2016383376B2 (en) | 2022-07-28 |
| CA3010097C (en) | 2023-08-22 |
| KR20180100152A (ko) | 2018-09-07 |
| RU2018126158A (ru) | 2020-01-31 |
| AU2016383376A1 (en) | 2018-07-12 |
| EP3398604A1 (en) | 2018-11-07 |
| CN106943420A (zh) | 2017-07-14 |
| US11058703B2 (en) | 2021-07-13 |
| JP2019500379A (ja) | 2019-01-10 |
| KR102676056B1 (ko) | 2024-06-19 |
| RU2018126158A3 (enExample) | 2020-03-11 |
| CA3010097A1 (en) | 2017-07-06 |
| EP3398604A4 (en) | 2019-06-19 |
| WO2017114413A1 (zh) | 2017-07-06 |
| CN118178446A (zh) | 2024-06-14 |
| RU2759916C2 (ru) | 2021-11-18 |
| HK1255689A1 (en) | 2019-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL285179A (en) | Pharmaceutical preparations containing synthetic glycans for use in the treatment of diseases of the digestive system and methods and methods for their preparation | |
| SG11201705361PA (en) | Acc inhibitor combination therapy for the treatment of non-alcoholic fatty liver disease | |
| IL234133B (en) | A medical preparation for the prevention and treatment of non-alcoholic fatty liver disease | |
| IL243481B (en) | A drug for the treatment of non-alcoholic fatty liver disease | |
| PT3031826T (pt) | Composição farmacêutica para o tratamento e/ou a prevenção do cancro | |
| PL2832365T3 (pl) | Kompozycja farmaceutyczna do leczenia i/lub zapobiegania nowotworowi wątroby | |
| GB201817116D0 (en) | Pharmaceutical preparation of palbociclic and preparation method thereof | |
| GB201411467D0 (en) | 7-hydroxy cannabidiol (7-oh-cbd) for use in the treatment of non-alcoholic fatty liver disease (nafld) | |
| IL265292A (en) | Medicinal compound and method for treating non-alcoholic fatty liver disease | |
| ZA201805080B (en) | Application of triacetyl-3-hydroxyphenyladenosine in preparation of pharmaceutical drug for preventing or treating non-alcoholic fatty liver disease | |
| SG11201605868XA (en) | Pharmaceutical composition for cancer treatment and pharmaceutical preparation for cancer treatment containing same composition as active ingredient | |
| IL265970B (en) | Sulfoxyalkyl organonitro compounds and related compounds and pharmaceutical preparations for use in medicine | |
| EP3290034A4 (en) | Use of trimethazine in preparation of drugs for preventing and treating liver diseases | |
| IL266486A (en) | Pharmaceutical preparations and methods for cancer treatment | |
| IL260890A (en) | Method and pharmaceutical composition for the treatment of neurodegeneration | |
| EP3318261A4 (en) | Use of zoledronic acid to prepare drug treating fatty liver disease | |
| GB201719675D0 (en) | Pharmaceutical composition for treating eczema and method for preparation thereof | |
| LT2957280T (lt) | Kieta farmacinė citizino kompozicija ir jos gamybos būdas | |
| GB201718475D0 (en) | Pharmaceutical composition for treatment of depression and preparation method thereof | |
| IL249860A0 (en) | Pharmaceutical preparations, methods for their preparation and their use for the treatment of cancer | |
| GB201718483D0 (en) | Pharmaceutical composition for treatment of meopausal syndrome and preparation method thereof | |
| GB201519644D0 (en) | Therapy and pharmaceutical composition | |
| IL275686A (en) | Use of preparations Preparation of a medicine for the treatment of the disease of small cerebral blood vessels | |
| IL257689B (en) | Pharmaceutical preparations and methods for treating diseases related to lack of oxygen | |
| IL251409B (en) | Phenylketone carboxylate compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis |